PT FAMON AWAL BROS SEDAYA TBK |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 665 IDR | +0.76% |
|
-0.75% | -5.67% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1,523B 94.4M | Sales 2023 | 1,839B 114M | Capitalization | 9,841B 610M |
|---|---|---|---|---|---|
| Net income 2022 | 62.5B 3.88M | Net income 2023 | 217B 13.45M | EV / Sales 2022 | 7.11 x |
| Net cash position 2022 | 201B 12.47M | Net Debt 2023 | 177B 10.95M | EV / Sales 2023 | 5.45 x |
| P/E ratio 2022 |
165
x | P/E ratio 2023 |
45.4
x | Employees | 5,623 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 8.24% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.75% | ||
| 1 week | -1.49% | ||
| Current month | -1.49% | ||
| 1 month | -2.22% | ||
| 3 months | -5.04% | ||
| 6 months | -2.94% | ||
| Current year | -6.38% |
1 week
650.00
665.00
1 month
650.00685.00
Current year
650.00730.00
1 year
650.00785.00
3 years
650.001 125.00
5 years
650.001 125.00
10 years
650.001 125.00
| Managers | Title | Age | Since |
|---|---|---|---|
Arfan Awaloeddin
CEO | Chief Executive Officer | 54 | 96-12-31 |
| Chief Executive Officer | 45 | 15-12-31 | |
| Comptroller/Controller/Auditor | 34 | 22-07-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 73 | 96-12-31 | |
| Director/Board Member | 63 | 21-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 665 | +0.76% | 28 800 |
| 24-05-14 | 660 | -0.75% | 28,000 |
| 24-05-13 | 665 | +0.76% | 22,500 |
| 24-05-08 | 660 | -1.49% | 15,700 |
| 24-05-07 | 670 | +0.75% | 2,500 |
End-of-day quote INDONESIA S.E., May 13, 2024
More quotes
PT Famon Awal Bros Sedaya Tbk is an Indonesia-based holding company. The Company is engaged in private hospital activities and management consulting. Its geographical segments include Jawa, Kalimantan dan/and Sulawesi and Sumatera. The Company conducts its activities through its subsidiaries in the healthcare services industry through several hospitals which are located in several cities in Indonesia. The Companyâs subsidiaries include PT Famon Global Medika; PT Fortuna Anugerah Sehati; PT Fortuna Anugerah Medika; PT Fortuna Graha Sentosa; PT Fortuna Prima Sentosa; PT Fortuna Sentosa Sejahtera; PT Global Prime System; PT Famon Medika Pangkalpinang, and others.
Calendar
2024-05-27
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -6.38% | 572M | |
| +18.41% | 83.94B | |
| -29.08% | 70.3B | |
| +3.59% | 27.46B | |
| -7.08% | 17.8B | |
| +2.07% | 17.46B | |
| +0.93% | 15.46B | |
| +6.78% | 13.49B | |
| +8.40% | 13.06B | |
| +68.45% | 12.96B |
- Stock Market
- Equities
- PRAY Stock
